Backing the Future of Health: Angel Investing in Medtech & Biotech

Backing the Future of Health: Angel Investing in Medtech & Biotech

Jul 28, 2025 · 82 min

Watch on

Suggest an edit

Join us for an exclusive online event where we dive into the dynamic world of angel investing in medtech and biotech. “Backing the Future of Health” brings together experienced investors, founders, and industry experts to explore the trends, opportunities, and challenges in funding the next generation of healthcare breakthroughs. Whether you're a seasoned investor or just beginning your journey into angel investing, this session will provide valuable insights into identifying high-potential startups, evaluating risk, and making impact-driven investment decisions in one of the world’s most vital and rapidly evolving sectors. Key Takeaways: Understand emerging trends in medtech and biotech innovation Learn how to evaluate early-stage health startups Hear firsthand from angels and entrepreneurs shaping the future of healthcare Discover the potential for financial return and societal impact Who Should Attend: New and aspiring investors Professionals looking to diversify their wealth Entrepreneurs interested in understanding the investor mindset Anyone curious about startup ecosystems in the health space Format: Panel discussion + Q&A + Networking in breakout rooms Bring your curiosity and your questions—we'll bring the insights. PANEL Sarah Shalaby is a medical doctor, specialist in digestive and liver diseases at Hospital Clínic of Barcelona, with expertise in liver transplantation and interventional management of conditions affecting blood flow in advanced liver disease (portal hypertension). Holding also a degree in Health Biotechnologies and a PhD in Oncology and Immunology, she collaborates internationally on liver disease research and guideline development. Melissa VanKirk is the Cofounder & COO of Primary Research Partners, a clinical research company on a mission to give primary care a front-row seat in medical innovation. With 16 years of industry experience spanning pharma, biotech, CRO, and site networks, she brings a 360-degree view of the clinical trial landscape. She has a proven track record of scaling businesses, optimizing operations, and driving growth across the life sciences sector. In addition to running PRP, Melissa advises early-stage biotech and medtech startups and is an active angel investor, bringing strategic, operational, and stakeholder-focused leadership with hands-on expertise in clinical operations and business strategy. Vanesa Nogales, with a career that combines sciences and executive strategy, Vanesa brings a comprehensive perspective to medtech investment. Holding a PhD in Biomedicine and an Executive MBA, she currently serves as Managing Director of a public hospital research institute, where she leads initiatives in innovation, technology transfer, and startup creation. Her experience includes evaluating emerging technologies, structuring investment strategies, and collaborating with public and private stakeholders to ensure a rigorous approach to expectation setting, project viability, and due diligence in the medtech sector. --- About the organizer SIA - Startup Investor Accelerator is a program for both startups and investors. For startups, it is an investment competition, where early-stage scalable startups receive an investment of 100-200K. For investors, SIA is a "Learning-by-doing" program, where participating new and experienced investors exercise and learn the ropes of Angel investing.

Conversation

No comments yet.